PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 2694 (103rd)

Pharmaceutical Interactions Safety Act

openUnited States· United States Congress· EN

Introduced

21 July 1993

Last action

15 September 1993 · Introduced

Status

Sponsor introductory remarks on measure. (CR E2186-2187)

Sponsors

Rep. Schroeder, Patricia [D-CO-1], Rep. Snowe, Olympia J. [R-ME-2]

Subjects

Healthcare

Source updated

3 June 2026

Healthcare

Summary

Pharmaceutical Interactions Safety Act - Amends the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to require that drug and biological product investigations include investigations of possible interactions of the drug or biological product with relevant female or male hormones.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 21 July 1993

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 21 July 1993

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 21 July 1993

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 3 September 1993

    Referred

    Referred to the Subcommittee on Health and the Environment.

    Source: Committee

  5. 15 September 1993

    Introduced

    Sponsor introductory remarks on measure. (CR E2186-2187)

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.